Eric Venker's Planned Sale of Roivant Sciences Common Shares

Eric Venker, an officer of Roivant Sciences Ltd., plans to sell 318,282 common shares of the company on October 16, 2025, pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025. The shares were acquired through the exercise of options granted on March 26, 2020. The aggregate market value of the shares to be sold is approximately $5,425,645.04. Additionally, Venker has engaged in multiple transactions over the past three months, selling a total of 3,136,427 common shares for gross proceeds exceeding $40 million. The sales were executed through Rockefeller Financial LLC and were reported under the same Rule 10b5-1 trading plan.